BioAsia 2019 to focus on disruption in healthcare, lifesciences & biotechnology

Hyderabad: BioAsia, the annual global life sciences confluence hosted by the Government of Telangana, announced that the 16th Edition of the event, to be held at Hyderabad between February 25th to 27th, 2019, will deliberate on the disruption required in Lifesciences, Healthcare and Biotech industry. The theme for this edition is “Life Sciences 4.0 – Disrupt the Disruption”, which will focus will be on healthcare being re-imagined as a result of technological disruption.

Mr ESL Narasimhan, Governor of Telangana will inaugurate the event on February 25, 2019. The details of the 16th edition of BioAsia were shared by Mr Jayesh Ranjan, Principle Secretary – Industries & Commerce & IT, Govt of Telangana in the presence of Mr K Satish Reddy, Chairman, Dr Reddy’s Laboratories, Mr Suresh Chukkapalli, Honorary Consul General, Republic of Korea (Hyderabad), Mr Shakthi M. Nagappan, CEO, BioAsia & Director (Life Sciences), Government of Telangana and Dr Srivari Chandrasekhar, Director, CSIR-IICT.

Over the past 15 years, BioAsia has helped attract investments to the tune of about Rs 15,000 crores and organized around 16,000 business partnering meetings during the event. Eminent leaders and senior government officials from around 95 countries have attended the event and close to 250 MoUs & LoIs have been exchanged at the forum. This edition of BioAsia has South Korea as the Partner Country with South Africa and Spain being the international partners for the event. These partners will lead a sizeable delegation from the related fields from their respective countries. 4 other Indian States have joined with BioAsia in organizing the next BioAsia including Karnataka, Odisha, Assam and Gujarat making it truly a National initiative.

While announcing the details, Mr Jayesh Ranjan, Principal Secretary – Industries and Commerce & IT, Govt of Telangana said, “BioAsia today serves as an industry platform for networking and policy advocacy in addition to investment promotion. The State Government is committed to utilize this global platform to advocate the concerns of the industry and help build a conducive ecosystem for businesses to thrive. As an outcome of the deliberations at the 15th edition of BioAsia, an Innovator Cell at Central Drugs Standard Control Organization (CDCSO) has now been established by the Government of India.”

The event will bring around 100 eminent speakers from across the globe, with some of the best minds and leaders from their fields, including Prof. Krishnamurthy Subramaniam, Chief Economic Advisor to Govt of India, Dr. Don Cleveland, Ludwig Cancer Research, Univ. of California, San Diego (Breakthrough Prize for Life Sciences 2018), Dr. Renu Swarup, Secretary, Department of Biotechnology, Government of India, Dr. S Eswara Reddy, DCGI, CDSCO, Mr. KT Rama Rao, Working President, TRS, Mr. Badhri Srinivasan – Head, Global Development Operations – Novartis, Mr. Kris Gopalakrishnan, Chairman, Axilor Ventures, Mr. Thomas Arista, Dy Director, US FDA, Mr. Kurt Stoeckli, President and Chief Scientific Officer, Glenmark Pharma, Mr. Glenn Saldanha, CMD, Glenmark Pharma, Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories, Ms. Karenann Terrell, Chief Digital and Technology Officer, GSK, UK, Mr. Peter Lee, Corporate Vice President, Microsoft Healthcare, USA, Mr. Atanu Roy, CIO, Sun Pharma and Ms. Sangita Reddy, Joint MD, Apollo Hospitals to name a few.